This map shows the geographic impact of W Helbig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Helbig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Helbig more than expected).
This network shows the impact of papers produced by W Helbig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Helbig. The network helps show where W Helbig may publish in the future.
Co-authorship network of co-authors of W Helbig
This figure shows the co-authorship network connecting the top 25 collaborators of W Helbig.
A scholar is included among the top collaborators of W Helbig based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with W Helbig. W Helbig is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Krahl, Rainer, et al.. (1990). Dose-reduced induction therapy for acute leukaemias decreases both the complete remission (CR) rate and the probability of leukaemia-free survival (LFS).. PubMed. 117(6). 783–6.1 indexed citations
10.
Leiblein, Sabine, et al.. (1989). Immune recovery following bone marrow transplantation.. PubMed. 116(3-4). 509–18.6 indexed citations
11.
Feyer, Petra, et al.. (1989). Acute and late effects in the course of and after total body irradiation with following bone marrow transplantation in patients with different forms of leukaemia.. PubMed. 116(3-4). 487–91.4 indexed citations
Hammer, Peter E., et al.. (1982). [Thrombocyte substitution in acute leukemia. Effect of histocompatibility on the clinical efficacy].. PubMed. 109(2). 355–64.1 indexed citations
14.
Helbig, W, et al.. (1982). [Prognostic significance of histobiopsy findings in bone marrow of malignant lymphomas in adults].. PubMed. 37(15). 491–7.
15.
Helbig, W. (1980). [Importance of paraneoplastic bone marrow and blood picture findings].. PubMed. 86. 428–32.2 indexed citations
16.
Helbig, W, et al.. (1970). [Hematology. Lymphatic and reticulohistocytic system].. PubMed. 112(45). 2057–63.1 indexed citations
Helbig, W & Gareth J. Thomas. (1965). [Roentgen findings in lymphogranulomatosis].. PubMed. 20(24). 1077–86.
19.
Helbig, W, et al.. (1963). [On the problem of the syntropy of leukemia and carcinoma].. PubMed. 21(3). 213–20.
20.
Helbig, W & M Weissel. (1961). [Treatment of chronic myelosis with Myleran (myeleukon) with special reference to alkaline leukocyte phosphatase activity].. PubMed. 103. 2390–5.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.